Publish Ahead of Print

Original Article

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis
Giorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, Luc Friboulet, Francesco Facchinetti
Timing of chronic obstructive pulmonary disease diagnosis in lung cancer prognosis: a clinical and genomic-based study
Jie Dai, Yanqi He, Kunlatida Maneenil, Han Liu, Ming Liu, Qian Guo, Amy C. Bennett, Shawn M. Stoddard, Jason A. Wampfler, Gening Jiang, Ping Yang
In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit
Yusuke Tomita, Bryan Oronsky, Nacer Abrouk, Pedro Cabrales, Tony R. Reid, Min-Jung Lee, Akira Yuno, Jonathan Baker, Sunmin Lee, Jane B. Trepel
Nogo-B promotes epithelial-mesenchymal transition in lung fibrosis via PERK branch of the endoplasmic reticulum stress pathway
Ying Zhu, Meng Yang, Xue-Hui Li, Wu-Jian Xu, Wei Gao, Yu-Han Chen, Jian-Dong Li, Qiang Li
In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit
Yusuke Tomita, Bryan Oronsky, Nacer Abrouk, Pedro Cabrales, Tony R. Reid, Min-Jung Lee, Akira Yuno, Jonathan Baker, Sunmin Lee, Jane B. Trepel
Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component
Masaki Suzuki, Rika Kasajima, Tomoyuki Yokose, Hiroyuki Ito, Eigo Shimizu, Seira Hatakeyama, Kazuaki Yokoyama, Rui Yamaguchi, Yoichi Furukawa, Satoru Miyano, Seiya Imoto, Emi Yoshioka, Kota Washimi, Yoichiro Okubo, Kae Kawachi, Shinya Sato, Yohei Miyagi

Review Article

Lung cancer screening: targeting the hard to reach—a review
Guido Van Hal, Paloma Diab Garcia
Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer
Steven Bozinovski, Amanda Vannitamby, Kanishka Rangamuwa, Savreet Aujla, Hao Wang, Christian Aloe, Louis Irving, Tracy T. Leong, Daniel P. Steinfort
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations
Roberto Ferrara, Diego Signorelli, Claudia Proto, Arsela Prelaj, Marina Chiara Garassino, Giuseppe Lo Russo
Thoracic radiotherapy in small cell lung cancer—a narrative review
Antonin Levy, Angela Botticella, Cécile Le Péchoux, Corinne Faivre-Finn
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
Mariacarmela Santarpia, Marco Massafra, Vittorio Gebbia, Antonio D’Aquino, Claudia Garipoli, Giuseppe Altavilla, Rafael Rosell
Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?
Anton Schreuder, Ernst T. Scholten, Bram van Ginneken, Colin Jacobs
Radiotherapy for thymic epithelial tumours: a review
Krisztian Süveg, Paul Martin Putora, Markus Joerger, Thomas Iseli, Galina Farina Fischer, Karlheinz Ammann, Markus Glatzer
An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
Ben G. L. Vanneste, Evert J. Van Limbergen, Kobe Reynders, Dirk De Ruysscher
Lung cancer screening: who pays? who receives?—the Chinese perspective
Yang Zhang, Haiquan Chen
Challenges in the target volume definition of lung cancer radiotherapy
Susan Mercieca, José S. A. Belderbos, Marcel van Herk
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
Boris Duchemann, Jordi Remon, Marie Naigeon, Lydie Cassard, Jean Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Edouard Auclin, Aude Desnoyer, Benjamin Besse, Nathalie Chaput
Exploring natural killer cell immunology as a therapeutic strategy in lung cancer
Jonas B. Hess, Kate D. Sutherland, Sarah A. Best
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
Kanishka Rangamuwa, Tracy Leong, Clare Weeden, Marie-Liesse Asselin-Labat, Steven Bozinovski, Michael Christie, Tom John, Phillip Antippa, Louis Irving, Daniel Steinfort
Should sublobar resection be offered for screening-detected lung nodules?
Alan D. L. Sihoe
Screen-detected solid nodules: from detection of nodule to structured reporting
Mario Silva, Gianluca Milanese, Roberta E. Ledda, Ugo Pastorino, Nicola Sverzellati
Prophylactic cranial irradiation in SCLC
Rafal Suwinski
The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review
Alistair R. Miller, Renee Manser
B cells in lung cancer—not just a bystander cell: a literature review
Tracy L. Leong, Vanessa L. Bryant
Managing of screening-detected sub-solid nodules—a European perspective
Sara Ricciardi, Richard Booton, Renè Horsleben Petersen, Maurizio Infante, Marco Scarci, Giulia Veronesi, Giuseppe Cardillo
Controversies in the role of radiotherapy in pleural mesothelioma
Gerard G. Hanna, Thomas John, David L. Ball
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question
Paul Van Houtte, Luigi Moretti, Florian Charlier, Martine Roelandts, Dirk Van Gestel
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
Eugenia Vlaskou Badra, Michael Baumgartl, Silvia Fabiano, Aurélien Jongen, Matthias Guckenberger
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
Man Zhang, Li Yan, Giuseppe Lippi, Zhi-De Hu
Dose and fractionation schedules in radiotherapy for non-small cell lung cancer
Lucyna Kepka, Joanna Socha
Evolving target volume concepts in locally advanced non-small cell lung cancer
Ursula Nestle, Cecile Le Pechoux, Dirk De Ruysscher
The radiologist’s role in lung cancer screening
Annemiek Snoeckx, Caro Franck, Mario Silva, Mathias Prokop, Cornelia Schaefer-Prokop, Marie-Pierre Revel
Managing screening-detected subsolid nodules—the Asian perspective
Masaaki Sato, Shun-Mao Yang, Dong Tian, Nakajima Jun, Jang-Ming Lee
Holding our breath: the promise of tissue-resident memory T cells in lung cancer
Claire Marceaux, Clare E. Weeden, Claire L. Gordon, Marie-Liesse Asselin-Labat
Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease
Francesco Passiglia, Valeria Cetoretta, Marco De Filippis, Valerio Napoli, Silvia Novello
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?
Lizza E. L. Hendriks, Jordi Remon, Jessica Menis, Benjamin Besse
Immunotherapy in oncogene addicted non-small cell lung cancer
Luke McLean, Jose Luis Leal, Benjamin J. Solomon, Thomas John
Immunotherapy in small cell lung cancer: one step at a time: a narrative review
Daphne W. Dumoulin, Anne-Marie C. Dingemans, Joachim G. J. V. Aerts, Jordi Remon, Dirk K. M. De Ruysscher, Lizza E. L. Hendriks
Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
Małgorzata Łazar-Poniatowska, Artur Bandura, Rafał Dziadziuszko, Jacek Jassem
Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents
Anna Wrona, Rafał Dziadziuszko, Jacek Jassem